Security Snapshot

Cencora, Inc. - Common Stock (COR) Institutional Ownership

CUSIP: 03073E105

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

1,453

Shares (Excl. Options)

182,349,349

Price

$337.75

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock
Symbol
COR on NYSE
Shares outstanding
194,661,096
Price per share
$324.80
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
182,349,349
Total reported value
$61,554,226,305
% of total 13F portfolios
0.03%
Share change
+4,523,231
Value change
+$1,583,349,298
Number of holders
1,453
Price from insider filings
$324.80
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • COR - Cencora, Inc. - Common Stock is tracked under CUSIP 03073E105.
  • 1453 institutions reported positions in Q4 2025.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 1,453 to 1,182 between Q4 2025 and Q1 2026.
  • Reported value moved from $61,554,226,305 to $28,065,548,919.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 1453 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 03073E105?
CUSIP 03073E105 identifies COR - Cencora, Inc. - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Cencora, Inc. - Common Stock (COR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.5% $4,760,462,571 16,405,771 BlackRock, Inc. 31 Dec 2024
VANGUARD CAPITAL MANAGEMENT LLC 7.3% $4,464,011,076 14,210,260 Vanguard Capital Management 31 Mar 2026
Walgreens Boots Alliance, Inc. 5% -8.8% $2,682,585,000 -$213,435,000 9,615,000 -7.4% Walgreens Boots Alliance, Inc. 09 Jun 2025

As of 31 Dec 2025, 1,453 institutional investors reported holding 182,349,349 shares of Cencora, Inc. - Common Stock (COR). This represents 94% of the company’s total 194,661,096 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Cencora, Inc. - Common Stock (COR) together control 64% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 12% 23,617,117 +0.95% 0.12% $7,976,681,267
BlackRock, Inc. 10% 20,286,079 +2.6% 0.12% $6,851,623,335
STATE STREET CORP 4.8% 9,305,507 +1.3% 0.11% $3,142,934,989
PRICE T ROWE ASSOCIATES INC /MD/ 3.6% 6,992,825 -9.5% 0.25% $2,361,828,000
T. Rowe Price Investment Management, Inc. 3.4% 6,700,091 +160% 1.4% $2,262,956,000
FMR LLC 2.8% 5,459,637 +65% 0.09% $1,843,992,352
GEODE CAPITAL MANAGEMENT, LLC 2.8% 5,459,476 +3.2% 0.11% $1,843,268,039
JPMORGAN CHASE & CO 2.6% 4,982,557 +6.5% 0.11% $1,682,859,251
WELLINGTON MANAGEMENT GROUP LLP 2.3% 4,535,992 +14% 0.27% $1,532,031,300
Boston Partners 2.2% 4,196,536 -6.9% 1.5% $1,418,419,534
Invesco Ltd. 2% 3,915,647 -2.3% 0.2% $1,322,509,818
BANK OF AMERICA CORP /DE/ 2% 3,871,070 -2.4% 0.1% $1,307,453,768
MORGAN STANLEY 1.5% 2,924,809 -12% 0.06% $987,854,987
Capital Research Global Investors 1.4% 2,749,577 +3.3% 0.17% $928,669,632
NORGES BANK 1.3% 2,435,250 0.09% $822,505,688
Amundi 1.1% 2,230,361 +34% 0.23% $753,304,427
NORTHERN TRUST CORP 1.1% 2,223,719 -2.1% 0.1% $751,061,093
GOLDMAN SACHS GROUP INC 1.1% 2,128,073 +33% 0.1% $718,756,907
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.81% 1,581,870 +7.2% 0.11% $534,276,594
DIMENSIONAL FUND ADVISORS LP 0.78% 1,513,478 +2.6% 0.11% $511,200,221
WELLS FARGO & COMPANY/MN 0.71% 1,379,935 +0.2% 0.09% $466,072,875
BESSEMER GROUP INC 0.7% 1,365,056 -28% 0.71% $461,047,000
Legal & General Group Plc 0.69% 1,350,258 -6.3% 0.1% $456,049,647
ROYAL BANK OF CANADA 0.68% 1,329,507 +20% 0.08% $449,041,000
NORDEA INVESTMENT MANAGEMENT AB 0.65% 1,256,356 +3.8% 0.37% $426,715,033

Institutional Holders of Cencora, Inc. - Common Stock (COR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 89,441,197 $28,065,548,919 -$948,110,615 $314.14 1,182
2025 Q4 182,349,349 $61,554,226,305 +$1,583,349,298 $337.75 1,453
2025 Q3 178,421,281 $55,710,336,744 +$473,565,524 $312.53 1,346
2025 Q2 184,305,787 $55,237,306,581 -$156,557,329 $299.85 1,332
2025 Q1 185,432,450 $51,572,943,235 -$2,176,096,083 $278.09 1,276
2024 Q4 193,624,028 $43,527,319,060 +$126,454,776 $224.68 1,216
2024 Q3 192,645,051 $43,376,425,534 -$1,022,988,419 $225.08 1,151
2024 Q2 196,987,201 $44,374,547,085 +$291,041,912 $225.30 1,128
2024 Q1 196,055,023 $47,610,586,760 +$36,365,827 $242.99 1,143
2023 Q4 169,402,915 $34,792,116,066 +$1,057,193,028 $205.38 1,073
2023 Q3 163,800,445 $29,500,837,104 +$846,056,057 $179.97 966
2023 Q2 159,099,312 $30,563,299,168 +$609,358,311 $192.43 997
2023 Q1 155,361,895 $24,878,992,155 +$535,210,813 $160.11 930
2022 Q4 153,609,147 $25,442,770,889 +$1,881,740,243 $165.71 969
2022 Q3 142,929,960 $19,380,264,681 -$40,535,017 $135.33 877
2022 Q2 142,616,744 $20,179,412,085 +$881,286,466 $141.48 882
2022 Q1 137,481,836 $21,266,943,430 +$446,997,474 $154.71 880
2021 Q4 134,863,306 $17,918,255,871 +$255,937,284 $132.89 849
2021 Q3 132,988,894 $15,886,064,854 -$64,811,380 $119.45 780
2021 Q2 133,529,140 $15,284,840,931 +$50,454,645 $114.49 781
2021 Q1 132,954,733 $15,692,224,672 +$244,238,636 $118.07 759
2020 Q4 131,476,972 $12,852,756,480 -$56,077,415 $97.76 763
2020 Q3 132,644,887 $12,844,894,440 -$105,591,704 $96.92 734
2020 Q2 132,899,146 $13,381,711,136 +$250,296,081 $100.77 726
2020 Q1 130,544,818 $11,547,042,489 -$443,110,986 $88.50 683
2019 Q4 135,999,026 $11,557,673,304 -$200,865,947 $85.02 705
2019 Q3 136,378,704 $11,224,934,497 -$130,898,983 $82.33 690
2019 Q2 137,744,844 $11,745,991,487 +$19,054,506 $85.26 688
2019 Q1 138,809,250 $11,039,024,457 +$87,504,022 $79.52 690
2018 Q4 138,165,884 $10,279,839,346 -$90,151,941 $74.40 697
2018 Q3 138,938,688 $12,810,309,890 -$366,283,937 $92.22 690
2018 Q2 142,793,616 $12,175,638,495 -$185,547,335 $85.27 716
2018 Q1 146,411,464 $12,600,038,248 -$117,693,651 $86.21 723
2017 Q4 145,712,520 $13,375,638,004 -$104,305,347 $91.82 723
2017 Q3 147,551,501 $12,198,514,057 -$132,336,414 $82.75 688
2017 Q2 148,611,272 $14,047,490,317 -$24,126,787 $94.53 706
2017 Q1 151,306,856 $13,385,994,977 +$1,627,943,237 $88.50 713
2016 Q4 145,638,620 $11,384,254,719 -$698,146,042 $78.19 688
2016 Q3 153,860,001 $12,417,178,526 -$381,169,792 $80.78 673
2016 Q2 159,293,689 $12,631,976,941 -$1,133,891,112 $79.32 677
2016 Q1 173,711,156 $15,026,637,338 -$239,375,754 $86.55 678
2015 Q4 176,281,194 $18,266,785,774 +$733,998,648 $103.71 706
2015 Q3 168,812,466 $16,026,973,253 -$73,739,088 $94.99 688
2015 Q2 169,527,201 $18,020,536,566 -$2,202,637,715 $106.34 705
2015 Q1 189,561,327 $21,531,287,892 +$286,427,131 $113.67 669
2014 Q4 188,369,166 $16,991,181,772 -$146,030,915 $90.16 648
2014 Q3 188,282,063 $14,555,324,113 -$222,208,459 $77.30 590
2014 Q2 190,780,536 $13,862,727,379 +$175,284,663 $72.66 581
2014 Q1 189,712,305 $12,441,406,565 -$396,165,732 $65.59 572
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .